Dr. Sikander Ailawadhi
Claim this profileMayo Clinic in Florida
Expert in Multiple Myeloma
Expert in Plasma Cell Neoplasm
21 reported clinical trials
28 drugs studied
Area of expertise
1Multiple Myeloma
Global Leaderchr1q positive
del17p positive
Stage III
2Plasma Cell Neoplasm
Global Leaderchr1q positive
del17p positive
Stage III
Affiliated Hospitals
Clinical Trials Sikander Ailawadhi is currently running
CFT7455
for Lymphoma
The purpose of this study is to characterize the safety, tolerability, pharmacokinetics, pharmacodynamics, and antitumor activity of oral cemsidomide (also known as CFT7455) administered at different dosages in subjects with Relapsed/Refractory (r/r) Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM). Cemsidomide may be administered as a single agent and, in MM only, in combination with oral dexamethasone.
Recruiting1 award Phase 1 & 210 criteria
Iberdomide vs Lenalidomide
for Multiple Myeloma
This trial is testing two treatments, iberdomide and lenalidomide, to see which one is better at preventing cancer from coming back in patients with newly diagnosed multiple myeloma after a stem cell transplant. These treatments help the immune system fight off cancer cells. Lenalidomide has been used for the treatment of multiple myeloma, showing effectiveness and improving survival outcomes.
Recruiting2 awards Phase 3
More about Sikander Ailawadhi
Clinical Trial Related4 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Sikander Ailawadhi has experience with
- Lenalidomide
- Dexamethasone
- Ibrutinib
- Daratumumab
- Bortezomib
- Pomalidomide
Breakdown of trials Sikander Ailawadhi has run
Multiple Myeloma
Plasma Cell Neoplasm
Cancer
Lymphoid Leukemia
T-Lymphoblastic Leukemia/Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sikander Ailawadhi specialize in?
Sikander Ailawadhi focuses on Multiple Myeloma and Plasma Cell Neoplasm. In particular, much of their work with Multiple Myeloma has involved chr1q positive patients, or patients who are del17p positive.
Is Sikander Ailawadhi currently recruiting for clinical trials?
Yes, Sikander Ailawadhi is currently recruiting for 9 clinical trials in Jacksonville Florida. If you're interested in participating, you should apply.
Are there any treatments that Sikander Ailawadhi has studied deeply?
Yes, Sikander Ailawadhi has studied treatments such as Lenalidomide, Dexamethasone, Ibrutinib.
What is the best way to schedule an appointment with Sikander Ailawadhi?
Apply for one of the trials that Sikander Ailawadhi is conducting.
What is the office address of Sikander Ailawadhi?
The office of Sikander Ailawadhi is located at: Mayo Clinic in Florida, Jacksonville, Florida 32224 United States. This is the address for their practice at the Mayo Clinic in Florida.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.